European Companies Search Engine

7 EU fundings (€263,659): Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections … BdlYear 2017 EU Research and Innovation programme "Horizon"

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AstraZeneca AB, Södertälje, Sweden.